The present invention relates to Mycoplasma bacteria, except to infection for the manufacture of a medicament for treating bacterial infections the compounds of formula (I), pharmaceutically acceptable acid or base addition salt, a stereochemically isomeric form or a N- oxide form of use will be:From here,R 1 is hydrogen, halo, C 1-6 alkyl poly to, C 1-6 alkyl, Ar or Het, andp is an integer of 1 or 2R 2 is C 1-6 alkyloxy, C 1-6 alkyloxy C 1-6 alkyloxy or C 1-6 alkylthio, andR 3 is Ar, Het or Het 1, andR 4 and R 5 are each independently hydrogen, C 1-6 alkyl or benzylR 4 and R 5 are lolly with blood, including the N to which they are bound pyridinyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrrolyl, imidazolidinyl, pyrazolyl Jolly pyridinyl, 2-imidazolinyl, 2 -pyrazol Jolly carbonyl, imidazolyl, pyrazolyl, triazolyl, piperidinyl, pyridinyl, piperazinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, morpholinyl and thiomorpholinyl groups of may form a radical selected from, and wherein each ring is C 1-6 alkyl, halo, C 1-6 alkyl, hydroxy, hydroxy C 1-6 alkyl, C 1-6 alkyloxy, amino-poly to, mono- or di (C 1-6 alkyl) optionally substituted by amino, C 1-6 alkylthio, C 1-6 alkyloxy C 1-6 alkyl, C 1-6 alkylthio C 1-6 alkyl or pyrimidinyl It may beR 6 is hydrogen, halo, C 1-6 alkyl poly to, C 1-6 alkyl, C 1-6 alkyloxy, C 1-6 alkylthio orTwo adjacent R6 radical is bonded to a second of the formula -CH = CH-CH = CH- to form together a radical, andr is an integer of 1 or 2R 7 is hydrogen, C 1-6 alkyl, Ar, Het or Het 1.본 발명은 마이코박테리아 감염을 제외한 세균 감염 치료용 의약의 제조를 위한 하기 화학식 (I)의 화합물, 그의 약제학적으로 허용되는 산 또는 염기 부가염, 입체화학적 이성체 형태 또는 N-옥사이드 형태의 용도에 관한 것이다:여기에서,R1은 수소, 할로, 폴리할로C1-6알킬, C1-6알킬, Ar 또는 Het이고p는 1 또는 2의 정수이며R2는 C1-6알킬옥시, C1-6알킬옥시C1-6알킬옥시 또는 C1-6알킬티오이고R3는 Ar, Het 또는 Het1이며R4 및 R5는 각각 독립적으로 수소, C1-6알킬 또는 벤질이거나R4 및 R5는 그들이 결합되는 N을 포함하여 함께 피롤리디닐, 2-피롤리닐, 3-피롤리닐, 피롤릴, 이미다졸리디닐, 피라졸리디닐, 2-이미다졸리닐, 2-피라졸리닐, 이미다졸릴, 피라졸릴, 트리아졸릴, 피페리디닐, 피리디닐, 피페라지닐, 피리다지닐, 피리미디닐, 피라지닐, 트리아지닐, 모폴리닐 및 티오모폴리닐의 그룹으로부터 선택되
